The overall goal of the Molecular Therapeutics and Drug Discovery Program (MTDDP) is to promote interactions along the continuum of basic, preclinical, and clinical research, to develop innovative approaches to drug treatment of solid tumors and hematologic malignancies.
Specifically, the MTDDP aims to:
- identify new anticancer agents;
- understand the mechanism(s) of action of new and existing anticancer drugs; and
- optimize schedules and doses of antineoplastic drugs.